A plain-language, continually updated guide from Dr. Matt Chalmers’ clinical reference on hormones and peptides.
Thymosin Alpha-1 has the strongest human clinical evidence of any peptide covered in our reference library: 80+ clinical trials, 11,000+ subjects studied, approved as a prescription medicine (Zadaxin) in 35+ countries, and FDA Orphan Drug Designation for hepatitis B since 1991.
Thymosin Alpha-1 is a naturally occurring 28-amino-acid peptide — the synthetic version is identical to what your body already makes — originally isolated from the thymus gland in 1977 by researcher Allan Goldstein. It’s essentially the thymus gland’s primary hormonal output. While it isn’t approved for commercial sale in the US, it’s approved as a prescription medicine called Zadaxin in more than 35 countries, and it’s available in the US through compounding pharmacies.
What makes this peptide genuinely unique in the immune-support space is bidirectional immune modulation: it can correct immune imbalances in either direction. If your immune system is underactive, it promotes T-cell maturation and the immune activity that’s missing. If your immune system is overactive (as in autoimmune conditions), it promotes the regulatory cells that calm things down. Very few compounds in this category can do both.
Thymosin Alpha-1 is most often considered for patients dealing with recurrent illness, immune imbalance, or a season of life where getting sick isn’t an option — think of it as an immune system reset, restoring things closer to how they’re designed to function. It’s important to be realistic: for serious conditions like HIV, this is not a cure, though it can meaningfully support the immune system alongside standard care. Whether it fits your protocol, and at what dose, is something our providers determine individually based on your health history and goals.
This is one of the best-studied compounds we discuss, with human trial data across several specific areas: viral suppression and improved outcomes in hepatitis B and C, a significant mortality reduction in a Phase 2 meta-analysis for moderate-to-severe COVID-19, immune-modulation benefit in critically ill sepsis patients (Phase III), enhanced immune response when combined with chemotherapy or radiation in cancer care, and improved vaccine responsiveness in elderly nursing-home populations. It’s also been studied specifically for immunosenescence — the natural decline in immune function with age — where it’s shown to restore some of the thymus gland’s declining function and improve how well the body responds to vaccines.
T-cell-mediated immune function depends on adequate protein and amino acid intake, along with zinc, vitamin D, vitamin C, and selenium — all established cofactors in normal immune system physiology that work alongside a compound like this rather than being replaced by it.
Thymosin Alpha-1 is not FDA-approved for commercial sale in the United States, though it holds FDA Orphan Drug Designation for hepatitis B (since 1991) and full approval as Zadaxin in more than 35 other countries. In the US, it’s available through licensed compounding pharmacies with a valid prescription. This page is educational and not an offer to treat any condition; whether it’s appropriate for you is determined through an individualized evaluation with our providers.
It has more human clinical evidence than almost any other compound we discuss — 80+ trials across viral illness, cancer support, sepsis, and vaccine response. It’s approved as a prescription drug (Zadaxin) in more than 35 countries and carries FDA Orphan Drug Designation for hepatitis B. It is not FDA-approved for general commercial sale in the US, so this page describes documented research rather than a claim about what it will do for any individual reader.
Its documented role in T-cell regulation — a core part of the body’s adaptive immune response — combined with its unusually deep human trial record, is the basis for this research interest. Few compounds in this space have this level of clinical documentation behind them.
This page draws on The Pillars Path: A Root-Cause Guide to Hormones, Peptides, and Metabolic Health by Dr. Matt Chalmers — Pillars of Wellness’ clinical reference on hormone and peptide therapy.